Diagnostic And Prognostic Importance Of Proteinuria In Development Of Chronic Kidney Disease In Persons With High Risk Factor
Keywords:
Abstract
Proteinuria, which is a predictor of early diagnosis of chronic kidney disease, is also a risk factor for the development and progression of renal pathology. The relationship is multifaceted and is built according to the type of feedback. On the one hand, the kidney can act as a target organ for most risk factors such as arterial hypertension, ischemic heart disease, diabetes mellitus, age, obesity associated with albuminuria. On the other hand, decreased renal function and severe albuminuria are an important reason for the accelerated development of end-stage chronic kidney disease.
Similar Articles
-
Modern Views Of Obesity –Comorbidity
The American Journal of Medical Sciences and Pharmaceutical Research: No. 08 (2020) / Isanova Shoira Tulkinovna, Abdullaeva Nargiza Nurmamatovna, Dzhurabekova Aziza Takhirovna, Mukhtarova Maftuna Alisherovna, Shomurodova Dilnoza Salimovna, -
State Of Purine Exchange And Microalbuminuria In Patients With Metabolic Syndrome
The American Journal of Medical Sciences and Pharmaceutical Research: No. 01 (2021) / Irodakhon Makhkambaevna Tashtemirova , -
Modern Views Of Obesity –Comorbidity
The American Journal of Medical Sciences and Pharmaceutical Research: No. 08 (2020) / Isanova Shoira Tulkinovna, Abdullaeva Nargiza Nurmamatovna, Dzhurabekova Aziza Takhirovna, Mukhtarova Maftuna Alisherovna, Shomurodova Dilnoza Salimovna, -
Assessment Of Clinical And Psychological Status And Quality Of Life Of Patients In Different Forms Of Irritable Bowel Syndrome
The American Journal of Medical Sciences and Pharmaceutical Research: No. 02 (2021) / Abdullayev R.B., Makhmudova L.I., -
Clinical Features Of Irritable Intestinal Syndrome
The American Journal of Medical Sciences and Pharmaceutical Research: No. 04 (2021) / Makhmudova L.I., Shazhanova N.S., Akhmedova N.Sh., -
COMPLICATIONS OF PARKES WEBER SYNDROME
The American Journal of Medical Sciences and Pharmaceutical Research: No. 12 (2022) / Munira S. Mahmudova, Surayyo M. Shukurdjanova, Nigora B. Nuritdinova, -
24-HOUR BLOOD PRESSURE MONITORING IN ADOLESCENTS WITH VEGETATIVE DYSTONIA SYNDROME
-
Role Of The PCSF Scale For Patients With Postcovid Syndrome
The American Journal of Medical Sciences and Pharmaceutical Research: No. 7 (2021) / Daminov B.T., Muminov D.K., Davron Kadirovich Muminov, -
Rational Use Of Drugs In The Comprehensive Treatment Of Bronchoobstructive Syndrome In Children
The American Journal of Medical Sciences and Pharmaceutical Research: No. 01 (2021) / Ismoilova Z.A.,, Rajabova N. T , Ishankulova N. N., -
The Role Of Leptin And Adiponectin In Disorders Of Fatter Tissue In Metabolic Syndrome
The American Journal of Medical Sciences and Pharmaceutical Research: No. 05 (2021) / Nelli Rafikovna Uzbekova,
References
Agranovich NV Justification and effectiveness of prevention and treatment of patients with chronic kidney disease in outpatient settings // Nephrology. St. Petersburg. 2013. Volume 17. No. 5, pages 43-48.
Vyalkova AA, Lebedeva EN et al. Clinical and pathogenetic aspects of kidney damage in obesity // Nephrology. St. Petersburg2014. Volume 18.No. 3, pages 24-33.
Nagaitseva S.S. Risk factors for increased albuminuria as an early marker of chronic kidney disease in different age groups // Nephrology. St. Petersburg. 2013 T. 17, No. 4. S. 58-62.
Nagaitseva S.S., Shvetsov M.Yu., Shalyagin Yu.D. Evaluation of albuminuria by test strips for the early detection of chronic kidney disease in individuals with different degrees of risk (experience of Health Centers of the Moscow Region) // Therapeutic Archives. Moscow. 2013. N26. S.38-43.
National recommendations. Chronic kidney disease: basic principles of screening, diagnosis, prevention and treatment approaches // Clinical Nephrology. Moscow. 2012. No. 4. S. 4-26.
Nephrology / ed. E. M. Shilova. //Moscow. GEOTAR-Media, 2007.S. 599-612
Nephrology: national guidelines / / ed. ON. Mukhina. Moscow. : GEOTAR-Media, 2009.720 p.
Smirnov A.V., Dobronravov V.A., Kayukov I.G. Chronic kidney disease: basic principles of screening, diagnosis, prevention and treatment approaches. National recommendations // Nephrology. St. Petersburg 2012. No. 1. S.89-115.
Imai E., Matsuo S., Makino H., Watanabe T. et al. Chronic Kidney Disease Japan Cohort (CKD-JAC) Study: Design and Methods // Hypertens Res. - 2008. - Vol.31, N6. - P. 1101-1107.
James MT, Hemmelgarn BR, Tonelli M: Early recognition and prevention of chronic kidney disease // Lancet 375.2010. Р 1296-1309
KDIGO. Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease // Kidney Int. USA / 2013. V.3, No.l. P.1-150.
Liam Manns, Nairne Scott-Douglas, 1 Marcello Tonelli, Robert Weaver, Helen Tam-Tham, and Brenda Hemmelgarn // A Population-Based Analysis of Quality Indicators in CKDClin J Am SocNephrol 12.2017. P 727-733
Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, Chen J, HeJ: A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010 // Kidney Int 882015. P 950-957
Noordzij M, Leffondre K, vanStralen KJ, Zoccali C, DekkerFW, Jager KJ: When do we need competing risks methods for survival analysis in nephrology? // Nephrol Dial Transplant28 2013.P: 2670-2677
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization // N England J Med. 2004. No. 351. P. 1296-1305.
